National Advertising Division Finds Brave, Inc. Claim that it Does Not Share Data with Third Parties Supported; Recommends Two Other Claims be Discontinued
703.247.9330 / firstname.lastname@example.org
New York, NY – June 22, 2022 – The National Advertising Division (NAD) of BBB National Programs determined that Brave, Inc. supported the implied claim that its Brave web browser does not share personal data with third parties. However, NAD recommended that the advertiser discontinue two other claims stating that:
- “Brave stops online surveillance.”
- “Shields everything . . . that can destruct your privacy.”
Brave is an open-source privacy company that offers Shields, a web browser feature that, according to the advertiser, protects a user’s privacy by blocking network requests for third-party advertising and tracking.
The claims at issue were challenged by NAD as part of its independent routine monitoring of truth and transparency in U.S. national advertising. In its inquiry, NAD examined online privacy protection claims, the accuracy of which consumers may not be able to assess on their own.
However, NAD noted that the challenged claims that Brave “stops online surveillance” and “shields everything that can destruct your property” are unqualified and affirmatively promise total protection from surveillance, third-party tracking, and that Brave will not share personal data with third parties.
In support of its claims, Brave relied on:
- The results of a study it conducted that reproduced searches on both Brave and Google Chrome to demonstrate the level of privacy protection provided in Brave through the Brave Shields feature, compared to the standard privacy settings in Google Chrome.
- A study designed to assess the privacy risks associated with backend data exchanges between servers that occurs during general web browsing, including whether a browser’s IP address can be tracked and if the browser discloses visits to third-party websites.
- Its use of other privacy safeguards including its own filter lists based on community reports of privacy issues or concerns, and engagement with third-party lists.
NAD determined that although Brave’s privacy protection might represent best practices in the industry, the evidence was not a good fit for the broad unqualified claims that Brave “stops online surveillance” and “shields everything that can destruct your privacy” and recommended that the claims be discontinued.
NAD noted that nothing in its decision prevents Brave from making properly qualified claims about its ability to protect consumers online.
In its advertiser statement, Brave stated that it “agrees to comply with NAD’s recommendations” . . . because it “strongly supports self-regulation and NAD’s mission.” The advertiser further stated that “while we disagree with NAD’s conclusion that the evidence Brave presented was ‘not a good fit’ for some of the statements that Brave used to describe its product, we no longer use” the two express claims that NAD examined.
National Advertising Review Board Refers Smile Prep’s Clear Aligners Advertising to FTC After Compliance Review
New York, NY – September 27, 2023 – The National Advertising Review Board (NARB) has referred advertising claims made by Smile Prep to the FTC for review and possible enforcement action after the company declined to accept NARB recommendations to modify certain claims and disclosures on its website.
National Advertising Division Recommends MacuHealth Discontinue or Modify Certain Claims for Several Brands of Eye Health Dietary Supplements
New York, NY – September 21, 2023 – In a challenge brought by Vision Elements, the National Advertising Division (NAD) recommended that MacuHealth modify or discontinue certain claims for its dietary supplement products.
National Advertising Division Refers Advertising by SBLA Beauty to the Federal Trade Commission for Review for Failure to Participate
New York, NY – September 21, 2023 – The National Advertising Division (NAD) has referred advertising claims made by SBLA Beauty, Inc. to the Federal Trade Commission (FTC) after the company failed to provide a substantive response to NAD’s inquiry.
Direct Selling Self-Regulatory Council Recommends Zallevo Discontinue Certain Earnings and Health-Related Product Claims
McLean, VA – August 31, 2023 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Zallevo modify or discontinue certain earnings and health-related product performance claims, including claims regarding treating serious health-related conditions.